Is NF-κB a good target for cancer therapy? Hopes and pitfalls
✍ Scribed by Baud, Véronique; Karin, Michael
- Book ID
- 109950722
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 454 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1474-1776
- DOI
- 10.1038/nrd2781
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract There are five nuclear factor‐__κ__B (NF‐__κ__B) transcription factors with important roles in innate immunity, liver inflammation, fibrosis and apoptosis prevention. Several inhibitors of NF‐__κ__B, like caffeic acid, captopril, curcumin, pyrrolidine dithiocarbamate, resveratrol, silym
## Abstract The p53 homologue p63 encodes multiple protein isoforms either with (TA) or without (ΔN) the N‐terminal transactivation domain. Accumulating evidence indicates that TAp63 plays an important role in various biological processes, including cell proliferation, differentiation, and apoptosi
## Abstract Critical processes underlying cancers must be better understood to develop strategies for treatment and prevention. A chemotherapeutic strategy is proposed that is based upon re‐establishment, with a drug, of nullified programmed cell death (apoptosis) in cancer cells, which to survive